Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the ...
Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
Company also reports preliminary unaudited 2024 revenue of $701.0 millionPARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver ...